Market Performance Summary – Wednesday, 21 October 2026
Clover Health Investments (CLOV)
- Closing price 07:06 AM Central Europe: USD 4.80
- 24‑hour change: ‑0.89 %
- 24‑hour trading volume: USD 16.9 million
- Total shares outstanding: 531.2 million
- Market capitalization: USD 2.4 billion
- Current price‑to‑earnings ratio: not provided
- Simple moving average (200 days): USD 3.45
- 52‑week high: USD 5.59 (29 June 2026)
- 52‑week low: USD 1.58 (1 April 2026)
Comparative 24‑hour performance of related stocks
| Ticker | 24‑hour change | Current price (USD) | Market cap (USD) | P/E ratio |
|---|---|---|---|---|
| Fervo Energy (FRVO) | –5.99 % | 9.29 | 2.9 billion | – |
| Atricure (ATRC) | –0.96 % | 57.67 | 2.9 billion | 267.03 |
| Teradata (TDC) | +3.26 % | 32.45 | 2.8 billion | 6.36 |
| Arcus Biosciences (RCUS) | +0.09 % | 23.75 | 2.8 billion | – |
| Denali Therapeutics (DNLI) | +2.44 % | 18.93 | 2.8 billion | – |
Company Overview
Clover Health Investments, Corp. is a U.S.‑based health‑care company that provides Medicare Advantage health plans. The company offers hospital, medical, and private‑insurance services to customers across the United States. Investors may trade Clover Health Investments’ shares on the Nasdaq exchange. Further information about the company’s products and services is available on its website at www.cloverhealth.com .
